The China NewCo Model Under Fire: A Legal Battle That Could Reshape Global Biotech
A legal battle in the U.S. over alleged trade secret misuse and double-dealing threatens to shake up how foreign companies operate in the American market. As we examine this case, it becomes clear that the implications stretch far beyond a single lawsuit.
Read full article







